The aim of this study was to investigate the role of upstream stimulatory factor‐1 (USF‐1) in the induction of radioresistance in prostate cancer and its targeting by histone deacetylase (HDAC) inhibitors to reverse resistance. The gene discussed is USF1; the disease is prostate cancer.